Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiora Pharmaceuticals (KPRX) Net Margin (2016 - 2024)

Kiora Pharmaceuticals (KPRX) has disclosed Net Margin for 8 consecutive years, with 11108.23% as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Net Margin changed N/A year-over-year to 11108.23%, compared with a TTM value of 60432.24% through Mar 2025, down 6045886.0%, and an annual FY2024 reading of 22.22%, changed N/A over the prior year.
  • Net Margin was 11108.23% for Q2 2024 at Kiora Pharmaceuticals, down from 84.08% in the prior quarter.
  • Across five years, Net Margin topped out at 348300.29% in Q4 2021 and bottomed at 83119.97% in Q1 2021.
  • Average Net Margin over 3 years is 41341.76%, with a median of 4823.79% recorded in 2024.
  • Peak annual rise in Net Margin hit 35803194bps in 2021, while the deepest fall reached 35803194bps in 2021.
  • Year by year, Net Margin stood at 9731.65% in 2020, then skyrocketed by 3679bps to 348300.29% in 2021, then tumbled by -103bps to 11108.23% in 2024.
  • Business Quant data shows Net Margin for KPRX at 11108.23% in Q2 2024, 84.08% in Q1 2024, and 348300.29% in Q4 2021.